Cypress Capital Group Zoetis Inc. Transaction History
Cypress Capital Group
- $813 Million
- Q3 2025
A detailed history of Cypress Capital Group transactions in Zoetis Inc. stock. As of the latest transaction made, Cypress Capital Group holds 10,319 shares of ZTS stock, worth $1.23 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
10,319
Previous 14,101
26.82%
Holding current value
$1.23 Million
Previous $2.2 Million
31.38%
% of portfolio
0.19%
Previous 0.28%
Shares
30 transactions
Others Institutions Holding ZTS
# of Institutions
2,088Shares Held
423MCall Options Held
1.87MPut Options Held
1.96M-
Vanguard Group Inc Valley Forge, PA42.3MShares$5.03 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$4.38 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.6MShares$2.33 Billion0.1% of portfolio
-
Morgan Stanley New York, NY16.9MShares$2.01 Billion0.16% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$1.89 Billion1.96% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $55.6B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...